Serum β-hydroxybutyrate and diagnostic interpretability of cardiac 18F-fluorodeoxyglucose positron emission tomography in suspected cardiac sarcoidosis.
- DOI
- 10.1016/j.nuclcard.2026.102945
- Published
- 2026 Aug 14
- Container
- Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.nuclcard.2026.102945,
title = {Serum β-hydroxybutyrate and diagnostic interpretability of cardiac 18F-fluorodeoxyglucose positron emission tomography in suspected cardiac sarcoidosis.},
author = {Hart H and Chen M and Vohra S and Ippolito P and Bimal T and Patel KK and Agarwal V},
year = {2026},
journal = {Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology},
doi = {10.1016/j.nuclcard.2026.102945},
url = {https://doi.org/10.1016/j.nuclcard.2026.102945}
}RIS
TY - JOUR TI - Serum β-hydroxybutyrate and diagnostic interpretability of cardiac 18F-fluorodeoxyglucose positron emission tomography in suspected cardiac sarcoidosis. AU - Hart H AU - Chen M AU - Vohra S AU - Ippolito P AU - Bimal T AU - Patel KK AU - Agarwal V PY - 2026 JO - Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology DO - 10.1016/j.nuclcard.2026.102945 UR - https://doi.org/10.1016/j.nuclcard.2026.102945 ER -
APA
H, H., M, C., S, V., P, I., T, B., KK, P., & V, A. (2026). Serum β-hydroxybutyrate and diagnostic interpretability of cardiac 18F-fluorodeoxyglucose positron emission tomography in suspected cardiac sarcoidosis.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. https://doi.org/10.1016/j.nuclcard.2026.102945
Source records
- pubmed · retrieved 2026-09-25T18:51:47.612Z